Evidence map›Paper›PMID 28606186›Full record

ArticleBMC complementary and alternative medicine2017

Comparison of chemical profiles between the root and aerial parts from three Bupleurum species based on a UHPLC-QTOF-MS metabolomics approach.

Lin Zhu, Zhi-Tao Liang, Tao Yi, Yue Ma, Zhong-Zhen Zhao, Bao-Lin Guo, Jian-Ye Zhang, Hu-Biao Chen

Abstract readComparative Study
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Alleviating Effects of Three Heat-InactivatedAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chemical components and protective effects ofWorld journal of gastroenterology · 2023
    Article
  9. Article
  10. Quantitative and Differential Analysis betweenMolecules (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Chromosome-Level Genome Assembly ofFrontiers in genetics · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lin ZhuSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Special Administrative Region, People's Republic of China.
Zhi-Tao LiangSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Special Administrative Region, People's Republic of China.
Tao YiSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Special Administrative Region, People's Republic of China.
Yue MaSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Special Administrative Region, People's Republic of China.
Zhong-Zhen ZhaoSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Special Administrative Region, People's Republic of China.
Bao-Lin GuoInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100094, China. guobaolin010@163.com.
Jian-Ye ZhangSchool of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 510182, China.
Hu-Biao ChenSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Special Administrative Region, People's Republic of China. hbchen@hkbu.edu.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBupleuri Radix (Chaihu) represents one of the most successful and widely used herbal medicines in Asia for the treatment of many diseases such as inflammatory disorders and infectious diseases over the past 2000 years. In the Chinese Pharmacopoeia, Chaihu is recorded as the dried roots of Bupleurum chinense DC. and B. scorzonerifolium Willd. (Umbelliferae). However, the widespread demand for the herb has tended to far outstrip the supply. Whether the aerial parts, which account for 70 ~ 85% of the dry weights of Bupleurum species, could be used as an alternative for the root has become an important scientific issue for the sustainable utilization of Bupleurum species. On the other hand, in some areas including the southeast of China as well as in Spain, the aerial parts of Bupleurum species have already been used in the folk medications. Therefore, to clarify whether the root and aerial parts of Bupleurum species are "equivalent" in the types and quantities of chemical constituents which subsequently influence their biological activities and therapeutic effects is of great importance for both the rational and sustainable use of this herb.

methodsIn the present study, the chemical profiles between the root and aerial parts of Bupleurum species from different species and collected from various locations were analyzed and compared by the ultra-high performance liquid chromatography quadrupole/time of flight-mass spectrometry (UHPLC-QTOF-MS).

resultsA total of 56 peaks were identified in the root and/or aerial parts from different batches of Bupleurum species, by comparison of references standards or with those reported in the literature. Principal Component Analysis (PCA) was conducted for displaying the differentiating clustering between these two parts.

conclusionThe results disclosed the distinct variations between them, which indicated that the aerial parts could not be used as an alternative of root from a chemodiversity perspective. The differentiating markers resulted from the PCA analysis could also be utilized for the differentiation between them. Further validation of their biological differences is anticipated in the future study.

Indexed as

BupleurumChinaChromatography, High Pressure LiquidDrugs, Chinese HerbalMass SpectrometryMetabolomicsPlant Components, AerialPlant RootsDrugs, Chinese HerbalBupleuri RadixChemical profilesMedicinal partsMetabolomics approach

Identifiers

PMID28606186
PMCPMC5468949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.